Atea Pharmaceuticalsinc Stock Cash And Equivalents
| AVIR Stock | USD 3.71 0.02 0.54% |
Atea PharmaceuticalsInc fundamentals help investors to digest information that contributes to Atea PharmaceuticalsI's financial success or failures. It also enables traders to predict the movement of Atea Stock. The fundamental analysis module provides a way to measure Atea PharmaceuticalsI's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Atea PharmaceuticalsI stock.
Atea | Cash And Equivalents |
Atea PharmaceuticalsInc Company Cash And Equivalents Analysis
Atea PharmaceuticalsI's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Atea PharmaceuticalsI Cash And Equivalents | 684.48 M |
Most of Atea PharmaceuticalsI's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Atea PharmaceuticalsInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Atea Cash And Equivalents Driver Correlations
Understanding the fundamental principles of building solid financial models for Atea PharmaceuticalsI is extremely important. It helps to project a fair market value of Atea Stock properly, considering its historical fundamentals such as Cash And Equivalents. Since Atea PharmaceuticalsI's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Atea PharmaceuticalsI's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Atea PharmaceuticalsI's interrelated accounts and indicators.
Click cells to compare fundamentals
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
Atea Cash And Cash Equivalents Changes
Cash And Cash Equivalents Changes |
|
In accordance with the recently published financial statements, Atea PharmaceuticalsInc has 684.48 M in Cash And Equivalents. This is 16.62% lower than that of the Pharmaceuticals sector and 53.09% higher than that of the Health Care industry. The cash and equivalents for all United States stocks is 74.67% higher than that of the company.
Atea Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Atea PharmaceuticalsI's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Atea PharmaceuticalsI could also be used in its relative valuation, which is a method of valuing Atea PharmaceuticalsI by comparing valuation metrics of similar companies.Atea PharmaceuticalsI is currently under evaluation in cash and equivalents category among related companies.
Atea PharmaceuticalsI Current Valuation Drivers
We derive many important indicators used in calculating different scores of Atea PharmaceuticalsI from analyzing Atea PharmaceuticalsI's financial statements. These drivers represent accounts that assess Atea PharmaceuticalsI's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Atea PharmaceuticalsI's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 2.5B | 3.4B | 740.4M | 400.4M | 254.3M | 241.6M | |
| Enterprise Value | 2.5B | 2.6B | (23.8M) | (243.2M) | 112.9M | 107.3M |
Atea Fundamentals
| Return On Equity | -0.23 | ||||
| Return On Asset | -0.12 | ||||
| Current Valuation | (263.45 M) | ||||
| Shares Outstanding | 84.16 M | ||||
| Shares Owned By Insiders | 9.46 % | ||||
| Shares Owned By Institutions | 67.74 % | ||||
| Number Of Shares Shorted | 1.75 M | ||||
| Price To Earning | 15.03 X | ||||
| Price To Book | 0.57 X | ||||
| Price To Sales | 1.90 X | ||||
| Gross Profit | (81.94 M) | ||||
| EBITDA | (163.75 M) | ||||
| Net Income | (135.96 M) | ||||
| Cash And Equivalents | 684.48 M | ||||
| Cash Per Share | 8.22 X | ||||
| Total Debt | 2.4 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 27.46 X | ||||
| Book Value Per Share | 6.65 X | ||||
| Cash Flow From Operations | (85.39 M) | ||||
| Short Ratio | 4.84 X | ||||
| Earnings Per Share | (1.63) X | ||||
| Target Price | 3.5 | ||||
| Number Of Employees | 75 | ||||
| Beta | 0.16 | ||||
| Market Capitalization | 312.25 M | ||||
| Total Asset | 594.97 M | ||||
| Retained Earnings | (195.84 M) | ||||
| Working Capital | 558.08 M | ||||
| Current Asset | 97.88 M | ||||
| Current Liabilities | 6.25 M | ||||
| Net Asset | 594.97 M |
About Atea PharmaceuticalsI Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Atea PharmaceuticalsInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Atea PharmaceuticalsI using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Atea PharmaceuticalsInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Atea PharmaceuticalsI
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Atea PharmaceuticalsI position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea PharmaceuticalsI will appreciate offsetting losses from the drop in the long position's value.Moving against Atea Stock
| 0.66 | ACB | Aurora Cannabis Sell-off Trend | PairCorr |
| 0.62 | RZLT | Rezolute Financial Report 9th of May 2024 | PairCorr |
| 0.61 | CGC | Canopy Growth Corp Financial Report 27th of June 2024 | PairCorr |
| 0.61 | SNDL | SNDL Inc Financial Report 20th of May 2024 | PairCorr |
| 0.57 | ELYM | Eliem Therapeutics Upward Rally | PairCorr |
The ability to find closely correlated positions to Atea PharmaceuticalsI could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Atea PharmaceuticalsI when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Atea PharmaceuticalsI - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Atea PharmaceuticalsInc to buy it.
The correlation of Atea PharmaceuticalsI is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Atea PharmaceuticalsI moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Atea PharmaceuticalsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Atea PharmaceuticalsI can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Atea PharmaceuticalsI Piotroski F Score and Atea PharmaceuticalsI Altman Z Score analysis. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Atea Stock analysis
When running Atea PharmaceuticalsI's price analysis, check to measure Atea PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea PharmaceuticalsI is operating at the current time. Most of Atea PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Atea PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atea PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Atea PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Stocks Directory Find actively traded stocks across global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is Atea PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atea PharmaceuticalsI. If investors know Atea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atea PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.641 | Earnings Share (1.63) | Revenue Per Share 2.31 | Quarterly Revenue Growth 2.952 | Return On Assets (0.12) |
The market value of Atea PharmaceuticalsInc is measured differently than its book value, which is the value of Atea that is recorded on the company's balance sheet. Investors also form their own opinion of Atea PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Atea PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atea PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Atea PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atea PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Atea PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atea PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.